Dr. Sean I. Savitz, Director of the Institute for Stroke and Cerebrovascular Diseases, shared key findings from the World Stroke Congress 2023 in Toronto Canada, shedding light on promising developments in stroke care. One noteworthy study he mentions, TENSION (NCT03094715), showcases the potential advantages of endovascular thrombectomy for individuals with significant core ischemic strokes identified through non-contrast CT scans.

Additionally, research exploring the neuroprotective effects of nerinetide, a peptide affecting NMDA receptor-PSD-95 protein interactions, suggests improved patient outcomes when administered within the first 60 minutes of a stroke (FRONTIER; NCT02315443).

Another intriguing revelation involves the ANNEXA-I study (NCT03661528), underscoring the significant effectiveness of andexanet alfa in treating patients with intracranial hemorrhage linked to the administration of factor Xa inhibitors.

These advancements signal a new era in stroke care.